Increased expression of TGF-β2 in osteoblasts results in an osteoporosis-like phenotype

Journal of Cell Biology

Volumn 132, Issue 1-2, 1996, Pages 195-210

  Erlebacher, Adrian ^a   Derynck, Rik ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MATRIX; BONE MINERALIZATION; BONE REMODELING; CLEIDOCRANIAL DYSPLASIA; GENE CONTROL; GENE EXPRESSION; METABOLIC BONE DISEASE; NONHUMAN; OSTEOBLAST; OSTEOPOROSIS; PHENOTYPE; PRIORITY JOURNAL; TRANSGENIC MOUSE;

AGE FACTORS; ANIMALS; BASE SEQUENCE; BONE AND BONES; BONE REMODELING; BONE RESORPTION; CALCIFICATION, PHYSIOLOGIC; CLAVICLE; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; OSTEOBLASTS; OSTEOCALCIN; OSTEOCLASTS; OSTEOPOROSIS; PHENOTYPE; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA; MUS MUSCULUS;

EID: 0029671373     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.132.1.195     Document Type: Article

References (67)

1. Araki, N., F. D. Robinson, and S. K Nishimoto. 1993. Rapid and sensitive method of quantitation of bone gla protein mRNA using competitive polymerase chain reaction. J. Bone Miner Res 8:313-322.
2. Baker, A. R., P. G. Hollingsnead, M. S. Pitts, S. Hansen, R. Taylor, and T. A. Stewart. 1992. Osteoblast-specific expression of growth hormone stimulates bone growth in transgenic mice. Mol. Cell Biol 12.5541-5547.
3. Bonewald, L. F., and S. L. Dallas. 1994. Role of active and latent transforming growth factor β in bone formation. J Cell. Biochem 55:350-357.
4. Bronckers, A. L., S Gay, M T Dimuzio, and W. T Butler. 1985 Immunolocalization of γ-carboxyglutamic acid containing proteins in developing rat bones. Coll Relat. Res. 5:273-281.
5. Brunner, A M , H. Marquardt, A. R Malacko, M N. Lioubin, and A. F. Purchio. 1989. Site-directed mutagenesis of cysteine residues in the pro region of the transforming growth factor β1 precursor Expression and characterization of mutant proteins. J. Biol Chem 264:13660-13664.
6. Centrella, M., M. C. Horowitz, J. M. Wozney, and T. L McCarthy. 1994 Transforming growth factor-β gene family members and bone Endocr. Rev 15: 27-39.
7. Centrella, M., T. L. McCarthy, and E. Canalis 1988. Parathyroid hormone modulates transforming growth factor β activity and binding in osteoblastenriched cell cultures from fetal rat parietal bone. Proc. Natl Acad. Sci. USA. 85:5889-5893.
8. Chenu, C., J Pfeilschifter, G. R Mundy, and G D Roodman. 1988 Transforming growth factor β inhibits formation of osteoclast-like cells in long-term human marrow cultures. Proc Natl Acad Sci USA. 85:5683-5687.
9. de Martin, R., B. Haendler, R. Hofer-Warbinek, H. Gaugitsch, M. Wrann, H. Schlusener, J. M. Seifert, S. Bodmer, A. Fontana, and E. Hofer. 1987. Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-β gene family. EMBO (Eur. Mol Biol. Organ) J. 6:3673-3677.
10. Dieudonné, S. C., P. Foo, E J. van Zoelen, and E. H. Burger 1991 Inhibiting and stimulating effects of TGF-β 1 on osteoclastic bone resorption in fetal mouse bone organ cultures. J Bone Miner. Res. 6:479-487.
11. Engler, B G., M. Meier, J. Frank, and G. A. Muller. 1993. Reduction of background problems in nonradioactive northern and Southern blot analyses enables higher sensitivity than 32P-based hybridizations. Anal Biochem. 210, 235-244
12. Erlebacher, A., E. H. Filvaroff, S. E. Gitelman, and R. Derynck. 1995. Toward a molecular understanding of skeletal morphogenesis. Cell 80:371-378.
13. Finkelman, R. D., N. H. Bell, D D Strong, L. M Demers, and D J Baylink 1992. Ovariectomy selectively reduces the concentration of transforming growth factor β in rat bone: implications for estrogen deficiency-associated bone loss. Proc Natl Acad. Sci. USA. 89.12190-12193.
14. Finkelman, R D , T. A. Linkhart, S Mohan, K. H. Lau, D. J. Baylink, and N H Bell 1991. Vitamin D deficiency causes a selective reduction in deposition of transforming growth factor β in rat bone: possible mechanism for impaired osteoinduction. Proc. Natl. Acad. Sci. USA. 88:3657-3660.
15. Frost, H. M. 1985. The skeletal intermediary organization: a synthesis. In Bone and Mineral Research. Vol. 3. W. A. Peck, editor. Elsevier, New York. pp. 49-107.
16. Groot, C. G., J. K. Danes, J. Blok, A. Hoogendijk, and P. V. Hauschka. 1986. Light and electron microscopic demonstration of osteocalcin antigenicity in embryonic and adult rat bone. Bone. 7:379-385.
17. Hall, B. K. 1986. The role of movement and tissue interactions in the development and growth of bone and secondary cartilage in the clavicle of the embryonic chick. J. Embryol. Exp. Morphol. 93:133-152.
18. Hattersley, G., and T. J. Chambers. 1991. Effects of transforming growth factor β 1 on the regulation of osteoclaslic development and function. J. Bone Miner. Res. 6:165-172.
19. Hogan, B., F. Constantini, and E. Lacy. 1986. Manipulating the Mouse Embryo. A Laboratory Manual. Cold Spring Harbor Laboratory. Cold Spring Harbor, NY. 332 pp.
20. Huang, S. S , P. O'Grady, and J. S. Huang. 1988. Human transforming growth factor β α 2-macroglobulin complex is a latent form of transforming growth factor β. J. Biol. Chem. 263.1535-1541.
21. Jones, K. L. 1988. Smith's Recognizable Patterns of Human Malformation. W.B. Saunders Co., Philadelphia, PA. pp. 362-363.
22. Joyce, M. E., A. B. Roberts, M. B. Sporn, and M E. Bolander. 1990. Transforming growth factor-β and the initiation of chondrogenesis and osteogenesis in the rat femur. J. Cell Biol 110:2195-2207
23. Kaufman, M H. 1992. The Atlas of Mouse Development. Academic Press, London, UK. pp. 507.
24. Kronenberg, H. M. 1993 Parathyroid hormone: mechanism of action. In Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. M. J. Favus, editor. Raven Press, New York. pp. 58-60.
25. Laird, P. W., A. Zijderveld, K. Linders, M. A. Rudnicki, R. Jaenisch, and A. Berns. 1991. Simplified mammalian DNA isolation procedure. Nucleic Acids Res. 19:4293-4294.
26. Lawrence, D. A., R. Pircher, and P. Jullien. 1985. Conversion of a high molecular weight latent β-TGF from chicken embryo fibroblasts into a low molecular weight active β-TGF under acidic conditions. Biochem. Biophys. Res. Commun 133:1026-1034.
27. Lewis, D. B., H. D. Liggitt, E. L Effmann, S. T. Motley, S. L. Teitelbaum, K. J. Jepsen, S. A. Goldstein, J. Bonadio, J Carpenter, and R. M Perlmutter. 1993. Osteoporosis induced in mice by overproduction of interleukin 4. Proc. Natl. Acad. Sci. USA. 90:11618-11622.
28. Malluche, H. H., and M. Faugere. 1990. Bone biopsies: histology and histomorphometry of bone. In Metabolic Bone Disease and Clinically Related Disorders. L. V. Avioland and S. M. Krane, editors. W. B. Saunders Co., Philadelphia, PA. pp. 283-328.
29. Manolagas, S. C., and R. L. Jilka 1995. Bone marrow, cytokines, and bone remodeling: emerging insights into the pathophysiology of osteoporosis. N. Engl. J. Med 332.305-311.
30. Marie, P., and P. Sainton. 1897. Observation d'hydrocephalie héréditaire (pere et fils) par vice de développement du crane et du cerveau. Bull Mem. Soc. Med Hop. (Paris). 14.706.
31. Massagué, J., S. Cheifetz, T. Endo, and B. Nadal-Ginard. 1986. Type β transforming growth factor is an inhibitor of myogenic differentiation. Proc. Natl. Acad. Sci. USA 83:8206-8210.
32. McSheehy, P. M., and T. J. Chambers. 1986. Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone. Endocrinology. 118:824-828.
33. Meunier, P. J., S. Sellami, D. Briançon, and C. Edouard. 1980. Histological heterogeneity of apparently idiopathic osteoporosis. In Osteoporosis: Recent Advances in Pathogenesis and Treatment. DeLuca, H. F., H. M. Frost, W. W S. Jee, C. C. Johnston, Jr., and A. M. Parfitt, editors. University Park Press, Baltimore, MD. pp. 293-301.
34. Miller, D. A., A. Lee, R. W. Pelton, E. Y. Chen, H. L. Moses, and R. Derynck. 1989. Murine transforming growth factor-β2 cDNA sequence and expression in adult tissues and embryos. Mol. Endocrinol. 89:1108-1114.
35. Mundy, G. R. 1993. Cytokines in bone. In Physiology and Pharmacology of Bone. Handbook of Experimental Pharmacology. G. R. Mundy and T. J. Martin, editors. Springer, New York. pp. 185-214.
36. Noda, M., and J J. Camilliere. 1989. In vivo stimulation of bone formation by transforming growth factor-β. Endocrinology. 124:2991-2994.
37. O'Connor, M. M., and L. M. Wakefield. 1987. Latent transforming growth factor-β in serum. A specific complex with α 2-macroglobulin. J. Biol. Chem 262:14090-14099.
38. O'Hare, K., C. Benoist, and R. Breathnach. 1981. Transformation of mouse fibroblasts to methotrexate resistance by a recombinant plasmid expressing a prokaryotic dihydrofolate reductase. Proc. Natl. Acad. Sci. USA. 78:1527-1531.
39. Olson, E. N., E. Sternberg, J. S. Hu, G. Spizz, and C. Wilcox. 1986. Regulation of myogenic differentiation by type β transforming growth factor. J. Cell Biol. 103:1799-1805.
40. Oursler, M. J., C. Cortese, P. Keeting, M. A. Anderson, S. K. Bonde, B. L. Riggs, and T. C. Spelsberg. 1991. Modulation of transforming growth factor-β production in normal human osteoblast-like cells by 17 β-estradiol and parathyroid hormone. Endocrinology. 129:3313-3320.
41. Pai, A. C. 1965. Developmental genetics of a lethal mutation, muscular dysgenesis (mdg) in the mouse. I. Genetic analysis and gross morphology. Dev Biol. 11:82-92.
42. Parfitt, A. M. 1983. The physiological and clinical significance of bone histomorphometric data. In Bone Histomorphometry: Techniques and Interpretation. R. R. Recker, editor. CRC Press, Boca Raton, FL. pp. 143-223.
43. Parfitt, A M. 1994. Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone. J. Cell. Biochem 55:273-286.
44. Parfitt, A. M., C. Mathews, D. Rao, B. Frame, M Kleerekoper, and A R Villanueva. 1980. Impaired osteoblast function in metabolic bone disease. In Osteoporosis: Recent Advances in Pathogenesis and Treatment. H. F DeLuca, H. M. Frost, W. W. S. Jee, C. C Johnston Jr., and A M. Parfitt, editors. University Park Press, Baltimore, MD pp. 321-330.
45. Pelton, R. W., B. Saxena, M Jones, H. L. Moses, and L. I. Gold. 1991. Immunohistochemical localization of TGF β 1, TGF β 2, and TGF β 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J Cell. Biol 115.1091-1105.
46. Pfeilschifter, J., and G. R. Mundy. 1987. Modulation of type β transforming growth factor activity in bone cultures by osteotropic hormones. Proc Natl. Acad Sci. USA 84:2024-2028.
47. Pfeilschifter, J., S. M. Seyedin, and G. R. Mundy. 1988. Transforming growth factor β inhibits bone resorption in fetal rat long bone cultures. J Clin Invest 82:680-685.
48. Pfeilschifter, F., F. Laukhuf, B. Muller-Beckmann, W. F. Blum, T. Pfister, and R. Ziegler. 1995. Parathyroid hormone increase the concentration of insulin-like growth factor-I and transforming growth factor-β 1 in rat bone. J Clin. Invest. 96:767-774.
49. Poh, V., R. Balena, E. Fattori, A. Markatos, M. Yamamoto, H. Tanaka, G Ciliberto, G. A. Rodan, and F. Costantini. 1994. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO (Eur. Mol. Biol. Organ.) J. 13:1189-1196.
50. Robey, P. G., M. F. Young, K. C. Flanders, N S. Roche, P. Kondaiah, A H. Reddi, J. D. Termine, M. B. Sporn, and A. B. Roberts. 1987. Osteoblasts synthesize and respond to transforming growth factor-type β (TGF-β) in vitro. J. Cell Biol. 105:457-463.
51. Rodan, G. A., and T. J. Martin. 1981. Role of osteoblasts in hormonal control of bone resorption - a hypothesis [letter]. Calcif. Tissue Int. 33:349-351.
52. Rosen, D., S. C. Miller, E. DeLeon, A. Y. Thompson, H. Bentz, M. Mathews, and S. Adams. 1994. Systemic administration of recombinant transforming growth factor β2 (rTGF-β2) stimulates parameters of cancellous bone formation in juvenile and adult rats. Bone. 15:355-359.
53. Sandberg, M., T. Vuorio, H. Hirvonen, K. Alitalo, and E. Vuorio. 1988 Enhanced expression of TGF-β and c-fos mRNAs in the growth plates of developing human long bones. Development. 102:461-470.
54. Schneider, H. G., V. P. Michelangeli, R. J. Frampton, J. L. Grogan, K. Ikeda, T J. Martin, and D. M. Findlay. 1992 Transforming growth factor-β modulates receptor binding of calciotropic hormones and G protein-mediated adenylate cyclase responses in osteoblast-like cells. Endocrinology 131:1383-1389.
55. Seitz, P. K., B. T. Zhu, and C. W. Cooper. 1992 Effect of transforming growth factor β on parathyroid hormone receptor binding and cAMP formation in rat osteosarcoma cell. J. Bone Miner Res. 7 541-546.
56. Seyedin, S. M., T. C Thomas, A Y. Thompson, D M. Rosen, and K A Piez. 1985. Purification and characterization of two cartilage-inducing factors from bovine demineralized bone. Proc Natl Acad. Sci. USA 82:2267-2271.
57. Sheehan, D. C., and B. B Hrapchak. 1980. Theory and practice of histotechnology, 2nd edition. Batelle Press, Columbus, OH. 481 pp.
58. Sillence, D. O., H. E. Ritchie, and P. B. Selby. 1987. Animal model: skeletal abnormalities in mice with cleidocranial dysplasia. Am. J. Med Genes 27 75-85.
59. Strewler, G. J., and R. A. Nissenson. 1993. Parathyroid hormone-related protein. In Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. M. J. Favus, editor. Raven Press, New York, NY. pp. 61-63.
60. Tashjian, A. J., E. F. Voelkel, M. Lazzaro, F. R. Singer, A. B. Roberts, R. Derynck, M. E. Winkler, and L. Levine. 1985. α and β human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria. Proc. Natl. Acad Sci. USA 82:4535-4538.
61. Tran, S., and B. K. Hall. 1989. Growth of the clavicle and development of clavicular secondary cartilage in the embryonic mouse. Acta Anat (Basel) 135: 200-207.
62. Vermeulen, A. H., C. Vermeer, and F. T. Bosman. 1989. Histochemical detection of osteocalcin in normal and pathological human bone. J. Histochem. Cytochem. 37:1503-1508.
63. Weibel, E. R. 1969. Stereological principles for morphometry in electron microscopic cytology. Int. Rev Cytol. 26:235-302.
64. Whyte, M. P., M. A. Bergfeld, W. A. Murphy, L. V. Avioli, and S. L. Teitelbaum. 1982. Postmenopausal osteoporosis, a heterogeneous disorder as assessed by histomorphometric analysis of iliac crest bone from untreated patients. Am J. Med. 72:193-202.
65. Wronski, T. J , P. L. Lowry, C. C. Walsh, and L. A. Ignaszewski 1985. Skeletal alterations in ovariectomized rats. Calcif. Tissue Int 37:324-328.
66. Wronski, T J., C. C. Walsh, and L. A Ignaszewski. 1986. Histologic evidence for osteopenia and increased bone turnover in ovariectomized rats. Bone 7: 119-123.
67. Yee, J A., L. Yan, J. C. Dominguez, E. H. Allan, and T. J Martin. 1993. Plasminogen-dependent activation of latent transforming growth factor beta (TGFβ) by growing cultures of osteoblast-like cells. J. Cell Physiol. 157:528-534.